Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: The value of real-time quantitative PCR

Current Opinion in Pharmacology

Volumn 11, Issue 5, 2011, Pages 486-493

  Seyedmousavi, Seyedmojtaba ^a   Melchers, Willem J G ^a   Verweij, Paul E ^a   Mouton, Johan W ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; DEOXYCHOLIC ACID; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; AREA UNDER THE CURVE; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL MODEL; FEASIBILITY STUDY; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 80053123693     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.08.001     Document Type: Review

References (42)

1. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, K.A. Marr, V.A. Morrison, B.H. Segal, W.J. Steinbach, and D.A. Stevens Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360 (Pubitemid 351265310)
2. E. Mavridou, R.J. Bruggemann, W.J. Melchers, J.W. Mouton, and P.E. Verweij Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene Antimicrob Agents Chemother 54 2010 860 865
3. P.E. Verweij, S.J. Howard, W.J. Melchers, and D.W. Denning Azole-resistance in Aspergillus: proposed nomenclature and breakpoints Drug Resist Updat 12 2009 141 147
4. P.E. Verweij, E. Snelders, G.H. Kema, E. Mellado, and W.J. Melchers Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis 9 2009 789 795
5. J.W. Mouton, P.G. Ambrose, R. Canton, G.L. Drusano, S. Harbarth, A. MacGowan, U. Theuretzbacher, and J. Turnidge Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective Drug Resist Updat 14 2011 107 117
6. J.R. Graybill Animal models for treatment of cryptococcosis Experimental Models in Antimicrobial Chemotherapy edn 3 1986 Academic Press 131-145
7. E. Mavridou, R.J. Bruggemann, W.J. Melchers, P.E. Verweij, and J.W. Mouton Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis Antimicrob Agents Chemother 54 2010 4758 4764
8. I.A. Bakker-Woudenberg Experimental models of pulmonary infection J Microbiol Methods 54 2003 295 313 (Pubitemid 36773973)
9. T.F. Patterson The future of animal models of invasive aspergillosis Med Mycol 43 Suppl 1 2005 S115 S119
10. V. Petraitis, R. Petraitiene, W.W. Hope, J. Meletiadis, D. Mickiene, J.E. Hughes, M.P. Cotton, T. Stergiopoulou, M. Kasai, and A. Francesconi Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose-dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis Antimicrob Agents Chemother 53 2009 2382 2391
11. J.P. Latge Aspergillus fumigatus and aspergillosis Clin Microbiol Rev 12 1999 310 350
12. L. Ostrosky-Zeichner, B.D. Alexander, D.H. Kett, J. Vazquez, P.G. Pappas, F. Saeki, P.A. Ketchum, J. Wingard, R. Schiff, and H. Tamura Multicenter clinical evaluation of the (1 → 3) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans Clin Infect Dis 41 2005 654 659 (Pubitemid 41170353)
13. C.D. Pfeiffer, J.P. Fine, and N. Safdar Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis Clin Infect Dis 42 2006 1417 1427
14. J. Loeffler, K. Kloepfer, H. Hebart, L. Najvar, J.R. Graybill, W.R. Kirkpatrick, T.F. Patterson, K. Dietz, R. Bialek, and H. Einsele Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis J Infect Dis 185 2002 1203 1206 (Pubitemid 34297783)
15. Z. Odabasi, G. Mattiuzzi, E. Estey, H. Kantarjian, F. Saeki, R.J. Ridge, P.A. Ketchum, M.A. Finkelman, J.H. Rex, and L. Ostrosky-Zeichner Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome Clin Infect Dis 39 2004 199 205 (Pubitemid 38971490)
16. L.J. Wheat Combination therapy for aspergillosis: is it needed, and which combination? J Infect Dis 187 2003 1831 1833 (Pubitemid 36724480)
17. K.V. Clemons, and D.A. Stevens Conventional or molecular measurement of Aspergillus load Med Mycol 47 Suppl 1 2009 S132 S137
18. J.C. Bowman, G.K. Abruzzo, J.W. Anderson, A.M. Flattery, C.J. Gill, V.B. Pikounis, D.M. Schmatz, P.A. Liberator, and C.M. Douglas Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate Antimicrob Agents Chemother 45 2001 3474 3481 (Pubitemid 33107865)
19. D.M. MacCallum, J.A. Whyte, and F.C. Odds Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis Antimicrob Agents Chemother 49 2005 3697 3701 (Pubitemid 41233020)
20. A. Gomez-Lopez, M.T. Martin-Gomez, P. Martin-Davila, P. Lopez-Onrubia, J. Gavalda, J. Fortun, A. Pahissa, J.L. Rodriguez-Tudela, and M. Cuenca-Estrella Detection of fungal DNA by real-time polymerase chain reaction: evaluation of 2 methodologies in experimental pulmonary aspergillosis Diagn Microbiol Infect Dis 56 2006 387 393 (Pubitemid 44854352)
21. A. Francesconi, M. Kasai, R. Petraitiene, V. Petraitis, A.M. Kelaher, R. Schaufele, W.W. Hope, Y.R. Shea, J. Bacher, and T.J. Walsh Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis J Clin Microbiol 44 2006 2475 2480 (Pubitemid 44092414)
22. C.E. O'Sullivan, M. Kasai, A. Francesconi, V. Petraitis, R. Petraitiene, A.M. Kelaher, A.A. Sarafandi, and T.J. Walsh Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis J Clin Microbiol 41 2003 5676 5682 (Pubitemid 37543265)
23. D.C. Sheppard, J.R. Graybill, L.K. Najvar, L.Y. Chiang, T. Doedt, W.R. Kirkpatrick, R. Bocanegra, A.C. Vallor, T.F. Patterson, and S.G. Filler Standardization of an experimental murine model of invasive pulmonary aspergillosis Antimicrob Agents Chemother 50 2006 3501 3503 (Pubitemid 44527538)
24. G. Singh, J. Imai, K.V. Clemons, and D.A. Stevens Efficacy of caspofungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods Antimicrob Agents Chemother 49 2005 1369 1376 (Pubitemid 40463364)
25. A.C. Vallor, W.R. Kirkpatrick, L.K. Najvar, R. Bocanegra, M.C. Kinney, A.W. Fothergill, M.L. Herrera, B.L. Wickes, J.R. Graybill, and T.F. Patterson Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture Antimicrob Agents Chemother 52 2008 2593 2598 (Pubitemid 351915692)
26. D.C. Sheppard, K.A. Marr, D.N. Fredricks, L.Y. Chiang, T. Doedt, and S.G. Filler Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis Clin Microbiol Infect 12 2006 376 380 (Pubitemid 43337528)
27. Y. Zhao, S. Park, P. Warn, R. Shrief, E. Harrison, and D.S. Perlin Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification J Clin Microbiol 48 2010 1378 1383
28. W. van Vianen, S. de Marie, M.T. ten Kate, R.A. Mathot, and I.A. Bakker-Woudenberg Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis J Antimicrob Chemother 57 2006 732 740
29. W.W. van de Sande, W. van Vianen, M.T. ten Kate, J. Vissers, J. Laurijsens, M. Tavakol, B.J. Rijnders, R.A. Mathot, and I.A. Bakker-Woudenberg Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis Antimicrob Agents Chemother 52 2008 1345 1350 (Pubitemid 351521997)
30. M.C. Arendrup, E. Mavridou, K.L. Mortensen, E. Snelders, N. Frimodt-Moller, H. Khan, W.J. Melchers, and P.E. Verweij Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence PLoS ONE 5 2010 e10080
31. C.G. Dennis, W.R. Greco, Y. Brun, R. Youn, H.K. Slocum, R.J. Bernacki, R. Lewis, N. Wiederhold, S.M. Holland, and R. Petraitiene Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease Antimicrob Agents Chemother 50 2006 422 427 (Pubitemid 43190948)
32. N.P. Wiederhold, D.P. Kontoyiannis, J. Chi, R.A. Prince, V.H. Tam, and R.E. Lewis Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity J Infect Dis 190 2004 1464 1471 (Pubitemid 39332186)
33. N.P. Wiederhold, V.H. Tam, J. Chi, R.A. Prince, D.P. Kontoyiannis, and R.E. Lewis Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis Antimicrob Agents Chemother 50 2006 469 473 (Pubitemid 43190954)
34. W.J. Melchers, P.E. Verweij, P. van den Hurk, A. van Belkum, B.E. De Pauw, J.A. Hoogkamp-Korstanje, and J.F. Meis General primer-mediated PCR for detection of Aspergillus species J Clin Microbiol 32 1994 1710 1717 (Pubitemid 24189561)
35. C. Mengoli, M. Cruciani, R.A. Barnes, J. Loeffler, and J.P. Donnelly Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis Lancet Infect Dis 9 2009 89 96
36. P.L. White, M.D. Perry, J. Loeffler, W. Melchers, L. Klingspor, S. Bretagne, E. McCulloch, M. Cuenca-Estrella, N. Finnstrom, and J.P. Donnelly The critical stages of extracting DNA from Aspergillus fumigatus in whole blood specimens J Clin Microbiol 2010
37. P.L. White, S. Bretagne, L. Klingspor, W.J. Melchers, E. McCulloch, B. Schulz, N. Finnstrom, C. Mengoli, R.A. Barnes, and J.P. Donnelly Aspergillus PCR: one step closer to standardization J Clin Microbiol 48 2010 1231 1240
38. C. Costa, D. Vidaud, M. Olivi, E. Bart-Delabesse, M. Vidaud, and S. Bretagne Development of two real-time quantitative TaqMan PCR assays to detect circulating Aspergillus fumigatus DNA in serum J Microbiol Methods 44 2001 263 269 (Pubitemid 32182378)
39. B. Spiess, D. Buchheidt, C. Baust, H. Skladny, W. Seifarth, U. Zeilfelder, C. Leib-Mosch, H. Morz, and R. Hehlmann Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients J Clin Microbiol 41 2003 1811 1818 (Pubitemid 36576496)
40. L. Millon, R. Piarroux, E. Deconinck, C.E. Bulabois, F. Grenouillet, P. Rohrlich, J.M. Costa, and S. Bretagne Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis J Clin Microbiol 43 2005 5097 5101 (Pubitemid 41484011)
41. P.L. White, and R.A. Barnes Aspergillus Pcplatforms, strengths and weaknesses Med Mycol 44 Suppl 2006
42. C. Landlinger, S. Preuner, B. Willinger, B. Haberpursch, Z. Racil, J. Mayer, and T. Lion Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology J Clin Microbiol 47 2009 1063 1073